GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Global Health Clinics Ltd (XCNQ:MJRX) » Definitions » Debt-to-EBITDA

Global Health Clinics (XCNQ:MJRX) Debt-to-EBITDA : -1.33 (As of Jan. 2024)


View and export this data going back to 2013. Start your Free Trial

What is Global Health Clinics Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Global Health Clinics's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jan. 2024 was C$0.88 Mil. Global Health Clinics's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jan. 2024 was C$0.33 Mil. Global Health Clinics's annualized EBITDA for the quarter that ended in Jan. 2024 was C$-0.91 Mil. Global Health Clinics's annualized Debt-to-EBITDA for the quarter that ended in Jan. 2024 was -1.33.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Global Health Clinics's Debt-to-EBITDA or its related term are showing as below:

XCNQ:MJRX' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -1.03   Med: -0.02   Max: 0
Current: -1.03

XCNQ:MJRX's Debt-to-EBITDA is ranked worse than
100% of 659 companies
in the Drug Manufacturers industry
Industry Median: 1.71 vs XCNQ:MJRX: -1.03

Global Health Clinics Debt-to-EBITDA Historical Data

The historical data trend for Global Health Clinics's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Global Health Clinics Debt-to-EBITDA Chart

Global Health Clinics Annual Data
Trend Jul14 Jul15 Jul16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22 Jul23
Debt-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.01 -0.02 - -0.24 -0.70

Global Health Clinics Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.54 -0.43 -0.99 -1.35 -1.33

Competitive Comparison of Global Health Clinics's Debt-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Global Health Clinics's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Global Health Clinics's Debt-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Global Health Clinics's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Global Health Clinics's Debt-to-EBITDA falls into.



Global Health Clinics Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Global Health Clinics's Debt-to-EBITDA for the fiscal year that ended in Jul. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(0.792 + 0.31) / -1.566
=-0.70

Global Health Clinics's annualized Debt-to-EBITDA for the quarter that ended in Jan. 2024 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(0.883 + 0.327) / -0.908
=-1.33

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Jan. 2024) EBITDA data.


Global Health Clinics  (XCNQ:MJRX) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Global Health Clinics Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Global Health Clinics's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Global Health Clinics (XCNQ:MJRX) Business Description

Traded in Other Exchanges
Address
837 West Hastings Street, Suite 400, Vancouver, BC, CAN, V6C 3N6
Global Health Clinics Ltd engages in the cannabis industry and operates medical clinics which guide patients through the process of becoming legal users of marijuana and also engages in developing psilocybin products for research and their potential usage for pharmaceutical purposes. The Company operates in two operating segments the operating of medical clinics to guide patients to become legal users of marijuana and the development of psilocybin products for research and potential usage for pharmaceutical purposes. The Company derives its key revenue from Medical Clinics for legal user of Marijuana.

Global Health Clinics (XCNQ:MJRX) Headlines

No Headlines